Boutique Biotech
Subscribe
Sign in
Home
Archive
Leaderboard
About
Latest
Top
Discussions
Mural Oncology in the spotlight (part II)
Assessing IL-18 for cancer treatment
Mar 12
•
Bohdan (Bo) Khomtchouk, Ph.D.
Share this post
Mural Oncology in the spotlight (part II)
boutiquebiotech.substack.com
Copy link
Facebook
Email
Note
Other
Akero Therapeutics in the spotlight
Data analysis and coverage of names in the GLP, MASH, fibrosis space
Mar 11
•
Bohdan (Bo) Khomtchouk, Ph.D.
Share this post
Akero Therapeutics in the spotlight
boutiquebiotech.substack.com
Copy link
Facebook
Email
Note
Other
January 2024
Modular Medical in the spotlight
Insulin Pump Awaits FDA Approval Amidst Competitive Market Dynamics and Funding Needs
Jan 22
•
Bohdan (Bo) Khomtchouk, Ph.D.
Share this post
Modular Medical in the spotlight
boutiquebiotech.substack.com
Copy link
Facebook
Email
Note
Other
Boutique trends we're watching in 2024
Federal reserve policies, M&A activity, and names we're following...
Jan 16
•
Bohdan (Bo) Khomtchouk, Ph.D.
Share this post
Boutique trends we're watching in 2024
boutiquebiotech.substack.com
Copy link
Facebook
Email
Note
Other
December 2023
Happy holidays from Boutique Biotech!
Bio M&A recap for 2023 and trends we're watching for 2024
Dec 26, 2023
•
Bohdan (Bo) Khomtchouk, Ph.D.
1
Share this post
Happy holidays from Boutique Biotech!
boutiquebiotech.substack.com
Copy link
Facebook
Email
Note
Other
Structure Therapeutics and POINT Biopharma in the spotlight
Updates and future outlook on $GPCR and $PNT, including $LNTH in the context of Novartis and Lilly
Dec 19, 2023
•
Bohdan (Bo) Khomtchouk, Ph.D.
Share this post
Structure Therapeutics and POINT Biopharma in the spotlight
boutiquebiotech.substack.com
Copy link
Facebook
Email
Note
Other
Mural Oncology in the spotlight
Deep dive on $MURA financials and market timing
Dec 14, 2023
•
Bohdan (Bo) Khomtchouk, Ph.D.
Share this post
Mural Oncology in the spotlight
boutiquebiotech.substack.com
Copy link
Facebook
Email
Note
Other
Diabetes medical devices in the spotlight
Recent updates on $PODD, $TNDM, $MODD, et al.
Dec 8, 2023
•
Bohdan (Bo) Khomtchouk, Ph.D.
Share this post
Diabetes medical devices in the spotlight
boutiquebiotech.substack.com
Copy link
Facebook
Email
Note
Other
Pfizer in the spotlight (part II)
Pfizer's obesity drug fails; market shifts to other GLP-1s.
Dec 4, 2023
•
Bohdan (Bo) Khomtchouk, Ph.D.
Share this post
Pfizer in the spotlight (part II)
boutiquebiotech.substack.com
Copy link
Facebook
Email
Note
Other
November 2023
Biotech Basics: Drug Pricing
Educational content for biotech investing
Nov 28, 2023
•
Bohdan (Bo) Khomtchouk, Ph.D.
Share this post
Biotech Basics: Drug Pricing
boutiquebiotech.substack.com
Copy link
Facebook
Email
Note
Other
Obesity in the spotlight (part V)
Happy Thanksgiving coverage of new names, big and small, including $KROS, $SRRK, $BHVN, $CRMO, et al.
Nov 23, 2023
•
Bohdan (Bo) Khomtchouk, Ph.D.
Share this post
Obesity in the spotlight (part V)
boutiquebiotech.substack.com
Copy link
Facebook
Email
Note
Other
Biotech Basics: IPOs
Educational content for biotech investing
Nov 20, 2023
•
Bohdan (Bo) Khomtchouk, Ph.D.
Share this post
Biotech Basics: IPOs
boutiquebiotech.substack.com
Copy link
Facebook
Email
Note
Other
Share
Copy link
Facebook
Email
Note
Other
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts